Key result
eNOS deficiency does not accelerate arterial thrombosis or meaningfully alter platelet aggregation.
Why the study?
The role of endothelial nitric oxide synthase in platelet activation, aggregation, and arterial thrombosis in vivo was unclear.
Does eNOS deficiency affect platelet aggregation and arterial thrombosis in mice?
Does eNOS deficiency affect platelet aggregation and arterial thrombosis in mice?
Endothelial NO synthase deficiency minimally affects platelet aggregation and is not associated with accelerated arterial thrombosis in vivo in mice.
Answers are grounded in this paper and cite their sources.
eNOS deficiency does not accelerate thrombosis in this mouse model; leaves open its role in human platelet function and arterial thrombosis.
Endothelial NO synthase (eNOS) expressed in the vascular endothelium or formed within platelets was postulated to inhibit platelet activation and aggregation. We have assessed the role of eNOS in platelet aggregation in vitro and in vivo by comparison of WT and eNOS-/- mice. Aggregometer studies revealed that collagen over a concentration range of 0.36-10 microg aggregated WT and eNOS-/- platelets to the same extent (10 microg: WT 86.7+/-4.7%, eNOS-/- 91+/-12%, n=6). Collagen treatment did not result in a significant increase in cGMP formation and VASP phosphorylation. Thrombin-induced P-selectin surface expression was unchanged in eNOS-/-platelets. In line with these findings no eNOS protein was detectable within the platelets of WT mice. In vivo, bleeding time after tail tip resection tended to be shorter in eNOS/- mice (WT: 116+/-35 s; eNOS-/- 109+/-37 s, n.s). Similarly, time to occlusion of the A.carotis after focal induction of thrombosis was 501+/-76 s (WT) and 457+/-95 s (eNOS-/-) (n.s.). These data demonstrate that eNOS-deficiency minimally affects platelet aggregation and is not associated with accelerated arterial thrombosis in vivo. Thus, in the mouse endothelial NO synthase does not play a major role in the autocrine modulation of platelet function and in thrombosis of conduit vessels in vivo.
No takes yet. Share an insight, caveat, or question.
Özüyaman et al. (2005) studied Arterial thrombosis. eNOS deficiency vs. Wild-type mice was evaluated on Time to occlusion of the A.carotis after focal induction of thrombosis (seconds) (p=n.s.). eNOS-deficiency minimally affected platelet aggregation and was not associated with accelerated arterial thrombosis in vivo (time to carotid occlusion 457 vs 501 s, n.s.).
Synapse has enriched 10 related papers. Consider them for comparative context: